Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 18, Number 2—February 2012
Research

Effect of Surveillance Method on Reported Characteristics of Lyme Disease, Connecticut, 1996–2007

Starr-Hope ErtelComments to Author , Randall S. Nelson, and Matthew L. Cartter
Author affiliations: Connecticut Department of Public Health, Hartford, Connecticut, USA

Main Article

Table 3

Clinical manifestations of Lyme disease, by surveillance method, Connecticut, 1996–2007*

Clinical manifestations No. (%) cases
PS, n = 12,185 AS, n = 8,666 ELS, n = 1,949 MLS, n = 10,657 Total, n = 33,457
Erythema migrans only 9,489 (77.9) 6,324 (73.0) 1,032 (53.0) 5,305 (49.8) 22,150 (66.2)
Late manifestations only 2,059 (16.9) 1,725 (19.9) 763 (39.1) 4,678 (43.9) 9,225 (27.6)
Both 637 (5.2) 617 (7.1) 154 (7.9) 674 (6.3) 2,082 (6.2)

*PS, passive surveillance; AS, active surveillance; ELS, enhanced laboratory surveillance; MLS, mandatory laboratory surveillance.

Main Article

Page created: January 19, 2012
Page updated: January 19, 2012
Page reviewed: January 19, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external